Ignite Creation Date:
2025-12-25 @ 2:31 AM
Ignite Modification Date:
2026-03-13 @ 8:33 AM
Study NCT ID:
NCT02288234
Status:
COMPLETED
Last Update Posted:
2019-01-15
First Post:
2014-11-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Telavancin Observational Use Registry (TOUR)
Sponsor:
Cumberland Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
0120
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None